Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Second-line Treatment of Stage III/IV Non-Small-Cell Lung Cancer (NSCLC) with pemetrexed in routine clinical practice: Evaluation of performance status and health-related quality of life

  • Wolfgang Schuette1,
  • Hans Tesch2,
  • Hartwig Büttner3,
  • Thomas Krause3,
  • Victoria Soldatenkova4 and
  • Clemens Stoffregen3Email author
BMC Cancer201212:14

DOI: 10.1186/1471-2407-12-14

Received: 8 June 2011

Accepted: 13 January 2012

Published: 13 January 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
8 Jun 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
28 Jul 2011 Reviewed Reviewer Report - alessandra bearz
31 Oct 2011 Reviewed Reviewer Report - David Spigel
6 Dec 2011 Author responded Author comments - Clemens Stoffregen
Resubmission - Version 3
6 Dec 2011 Submitted Manuscript version 3
12 Dec 2011 Author responded Author comments - Clemens Stoffregen
Resubmission - Version 4
12 Dec 2011 Submitted Manuscript version 4
Publishing
13 Jan 2012 Editorially accepted
13 Jan 2012 Article published 10.1186/1471-2407-12-14

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Hospital Martha-Maria, Halle-Doelau, Department of Internal Medicine II
(2)
Hospital Bethanien, Group Practice Oncology
(3)
Medical Department, Lilly Deutschland GmbH, Bad Homburg
(4)
Statistics Oncology, Lilly Deutschland GmbH

Advertisement